U.S. Capital Wealth Advisors’s Sanofi SNY Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$268K	Sell	5,554 -513	-8%	-$23.9K	0.01%	864
2025 Q4	$294K	Sell	6,067 -627	-9%	-$31.1K	0.01%	814
2025 Q3	$316K	Buy	6,694 +467	+7%	+$22.5K	0.01%	759
2025 Q2	$301K	Buy	6,227 +247	+4%	+$12.6K	0.01%	709
2025 Q1	$332K	Buy	+5,980	New	+$324K	0.01%	681
2024 Q1	–	Sell	-7,951	Closed	-$395K	–	704
2023 Q4	$395K	Buy	7,951 +2,515	+46%	+$123K	0.02%	495
2023 Q3	$292K	Buy	5,436 +11	+0.2%	+$586	0.01%	523
2023 Q2	$292K	Sell	5,425 -156	-3%	-$8.39K	0.01%	539
2023 Q1	$304K	Sell	5,581 -100	-2%	-$4.86K	0.01%	531
2022 Q4	$275K	Sell	5,681 -2,067	-27%	-$90.7K	0.01%	549
2022 Q3	$295K	Sell	7,748 -1,702	-18%	-$75.8K	0.01%	520
2022 Q2	$473K	Sell	9,450 -2,050	-18%	-$109K	0.02%	474
2022 Q1	$590K	Sell	11,500 -1,595	-12%	-$82.4K	0.02%	479
2021 Q4	$656K	Sell	13,095 -200	-2%	-$9.89K	0.03%	463
2021 Q3	$641K	Buy	+13,295	New	+$676K	0.03%	467

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

U.S. Capital Wealth Advisors's SNY Position: Q1 2026 in Review

U.S. Capital Wealth Advisors reduced its Sanofi (SNY) stake by 8.5% in Q1 2026, selling an estimated $23.9K and leaving 5,554 shares worth $268K. The position accounts for 0.01% of the portfolio, ranked #864.

U.S. Capital Wealth Advisors first reported a position in SNY in Q3 2021 and has held it in 15 quarters since. The position peaked at $656K in Q4 2021. 739 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

U.S. Capital Wealth Advisors held 5,554 shares of Sanofi worth $268K as of Q1 2026.
U.S. Capital Wealth Advisors sold 513 Sanofi shares in Q1 2026, an estimated $23.9K.
Sanofi made up 0.01% of U.S. Capital Wealth Advisors's portfolio in Q1 2026, its #864 holding.
U.S. Capital Wealth Advisors first reported a position in Sanofi in Q3 2021 and has held it in 15 quarters since.
U.S. Capital Wealth Advisors's Sanofi position peaked at $656K in Q4 2021.
739 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.